These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 11874177

  • 21. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S, Van den Broeck J, Sas T, Hokken-Koelega A.
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [Abstract] [Full Text] [Related]

  • 22. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
    [Abstract] [Full Text] [Related]

  • 23. Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial.
    Gault EJ, Cole TJ, Casey S, Hindmarsh PC, Betts P, Dunger DB, Donaldson MDC.
    Arch Dis Child; 2021 Jan; 106(1):74-76. PubMed ID: 31862699
    [Abstract] [Full Text] [Related]

  • 24. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.
    Mohamed S, Alkofide H, Adi YA, Amer YS, AlFaleh K.
    Cochrane Database Syst Rev; 2019 Oct 30; 2019(10):. PubMed ID: 31684688
    [Abstract] [Full Text] [Related]

  • 25. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
    Gault EJ, Perry RJ, Cole TJ, Casey S, Paterson WF, Hindmarsh PC, Betts P, Dunger DB, Donaldson MD, British Society for Paediatric Endocrinology and Diabetes.
    BMJ; 2011 Apr 14; 342():d1980. PubMed ID: 21493672
    [Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC, Gault EJ, Bardsley MZ, Menke LA, Freriks K, Perry RJ, Otten BJ, de Muinck Keizer-Schrama SM, Timmers H, Wit JM, Ross JL, Donaldson MD.
    Horm Res Paediatr; 2014 Apr 14; 81(5):289-97. PubMed ID: 24776783
    [Abstract] [Full Text] [Related]

  • 27. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG, Hintz RL, Johanson AJ, Brasel JA, Burstein S, Chernausek SD, Clabots T, Frane J, Gotlin RW, Kuntze J.
    J Pediatr; 1986 Dec 14; 109(6):936-43. PubMed ID: 3537249
    [Abstract] [Full Text] [Related]

  • 28. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.
    Perry RJ, Gault EJ, Paterson WF, Dunger DB, Donaldson MD.
    Horm Res Paediatr; 2014 Dec 14; 81(5):298-308. PubMed ID: 24751470
    [Abstract] [Full Text] [Related]

  • 29. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 14; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama SM, Sas TC.
    Acta Paediatr Suppl; 1999 Dec 14; 88(433):126-9. PubMed ID: 10626563
    [Abstract] [Full Text] [Related]

  • 31. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.
    Johnston DI, Betts P, Dunger D, Barnes N, Swift PG, Buckler JM, Butler GE.
    Arch Dis Child; 2001 Jan 14; 84(1):76-81. PubMed ID: 11124794
    [Abstract] [Full Text] [Related]

  • 32. Turner syndrome.
    Ranke MB.
    Eur J Endocrinol; 1999 Sep 14; 141(3):216-7. PubMed ID: 10474117
    [No Abstract] [Full Text] [Related]

  • 33. Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.
    Job JC, Landier F.
    Horm Res; 1991 Sep 14; 35(6):229-33. PubMed ID: 1819547
    [Abstract] [Full Text] [Related]

  • 34. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM, Passeri F, Municchi G, Segni M, Pucarelli I, Larizza D, Bossi G, Severi F, Galasso C.
    Horm Res; 1996 Sep 14; 46(6):269-72. PubMed ID: 8982737
    [Abstract] [Full Text] [Related]

  • 35. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 2003 Mar 14; 88(3):1119-25. PubMed ID: 12629094
    [Abstract] [Full Text] [Related]

  • 36. Final height in young women with Turner syndrome after GH therapy: an open controlled study.
    Hochberg Z, Zadik Z.
    Eur J Endocrinol; 1999 Sep 14; 141(3):218-24. PubMed ID: 10474118
    [Abstract] [Full Text] [Related]

  • 37. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005 Sep 14; 11(2):79-84. PubMed ID: 15996336
    [Abstract] [Full Text] [Related]

  • 38. Growth response and final height in Turner syndrome after combination therapy of growth hormone and anabolic steroid.
    Shu SG.
    Acta Paediatr Taiwan; 2000 Sep 14; 41(6):322-6. PubMed ID: 11198939
    [Abstract] [Full Text] [Related]

  • 39. Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood.
    Kriström B, Ankarberg-Lindgren C, Barrenäs ML, Nilsson KO, Albertsson-Wikland K.
    Front Endocrinol (Lausanne); 2023 Sep 14; 14():1197897. PubMed ID: 37529614
    [Abstract] [Full Text] [Related]

  • 40. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM.
    J Pediatr; 1992 Jul 14; 121(1):49-55. PubMed ID: 1625092
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.